Breast cancer antibodies: Atlas Antibodies

These highly validated breast cancer antibodies are from the Triple A Polyclonal and PrecisA Monoclonal ranges of Atlas Antibodies. Antibodies within the Triple A Polyclonal range have been identified by the Human Protein Atlas project, which demonstrate differential IHC staining patterns in breast cancer samples.

The antibodies from the Triple A range have been tested in:
• Normal breast samples from three different individuals
• Breast tumour samples from up to 12 patients in duplicates
• Metastatic breast adenocarcinoma cell lines MCF-7 and SK-BR-3

We also offer antibodies to established clinical breast cancer markers shown in the table below:

Anti-HER2 Antibody (AMAb90627) Left: Immunohistochemical staining of human HER2-positive breast cancer shows strong membranous positivity in tumour cells. Middle: Immunohistochemical staining of human HER2-negative breast cancer hows no positivity in tumour cells, as expected. Right: Western blot analysis in human cell line SK-BR-3 and human cell line MCF-7.

Anti-MKI67 polyclonal antibody (HPA000451) Left: Immunohistochemical staining of human lymph node shoes moderate to strong nuclear positivity in germinal center cells. Right: Immunohistochemical staining of human bone marrow shows strong nuclear positivity in hematopoietic cells. 

Below is a small selection of breast cancer antibodies available. For a full list please contact our Atlas Antibodies specialist.

Material available for download
Atlas Antibodies in breast cancer research brochure